Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1998 Mar;51(3):183–188. doi: 10.1136/jcp.51.3.183

ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease.

R A Still 1, I F McDowell 1
PMCID: PMC500636  PMID: 9659257

Abstract

Plasma homocysteine is emerging as an important risk factor for cardiovascular disease. Measurement in clinical laboratories is feasible by several techniques, including HPLC. Of particular importance is the potential for treatment by dietary modification and vitamin supplements, particularly folic acid. The outcome of vitamin intervention on cardiovascular events is awaited with interest. If the role of homocysteine is confirmed then it may rival cholesterol in importance as a cardiovascular risk factor.

Full text

PDF
183

Images in this article

187Image
on p.187

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellamy M. F., McDowell I. F. Putative mechanisms for vascular damage by homocysteine. J Inherit Metab Dis. 1997 Jun;20(2):307–315. doi: 10.1023/a:1005377310872. [DOI] [PubMed] [Google Scholar]
  2. Bostom A. G., Roubenoff R., Dellaripa P., Nadeau M. R., Sutherland P., Wilson P. W., Jacques P. F., Selhub J., Rosenberg I. H. Validation of abbreviated oral methionine-loading test. Clin Chem. 1995 Jun;41(6 Pt 1):948–949. [PubMed] [Google Scholar]
  3. Boushey C. J., Beresford S. A., Omenn G. S., Motulsky A. G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995 Oct 4;274(13):1049–1057. doi: 10.1001/jama.1995.03530130055028. [DOI] [PubMed] [Google Scholar]
  4. Dudman N. P., Guo X. W., Crooks R., Xie L., Silberberg J. S. Assay of plasma homocysteine: light sensitivity of the fluorescent 7-benzo-2-oxa-1, 3-diazole-4-sulfonic acid derivative, and use of appropriate calibrators. Clin Chem. 1996 Dec;42(12):2028–2032. [PubMed] [Google Scholar]
  5. Duell P. B., Malinow M. R. Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol. 1997 Feb;8(1):28–34. doi: 10.1097/00041433-199702000-00007. [DOI] [PubMed] [Google Scholar]
  6. Evrovski J., Callaghan M., Cole D. E. Determination of homocysteine by HPLC with pulsed integrated amperometry. Clin Chem. 1995 May;41(5):757–758. [PubMed] [Google Scholar]
  7. Fiskerstrand T., Refsum H., Kvalheim G., Ueland P. M. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem. 1993 Feb;39(2):263–271. [PubMed] [Google Scholar]
  8. Garg U. C., Zheng Z. J., Folsom A. R., Moyer Y. S., Tsai M. Y., McGovern P., Eckfeldt J. H. Short-term and long-term variability of plasma homocysteine measurement. Clin Chem. 1997 Jan;43(1):141–145. [PubMed] [Google Scholar]
  9. Graham I. M., Daly L. E., Refsum H. M., Robinson K., Brattström L. E., Ueland P. M., Palma-Reis R. J., Boers G. H., Sheahan R. G., Israelsson B. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997 Jun 11;277(22):1775–1781. doi: 10.1001/jama.1997.03540460039030. [DOI] [PubMed] [Google Scholar]
  10. Guttormsen A. B., Schneede J., Fiskerstrand T., Ueland P. M., Refsum H. M. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr. 1994 Oct;124(10):1934–1941. doi: 10.1093/jn/124.10.1934. [DOI] [PubMed] [Google Scholar]
  11. Harmon D. L., Woodside J. V., Yarnell J. W., McMaster D., Young I. S., McCrum E. E., Gey K. F., Whitehead A. S., Evans A. E. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM. 1996 Aug;89(8):571–577. doi: 10.1093/qjmed/89.8.571. [DOI] [PubMed] [Google Scholar]
  12. Israelsson B., Brattström L. E., Hultberg B. L. Homocysteine and myocardial infarction. Atherosclerosis. 1988 Jun;71(2-3):227–233. doi: 10.1016/0021-9150(88)90147-5. [DOI] [PubMed] [Google Scholar]
  13. Kuo K., Still R., Cale S., McDowell I. Standardization (external and internal) of HPLC assay for plasma homocysteine. Clin Chem. 1997 Sep;43(9):1653–1655. [PubMed] [Google Scholar]
  14. Lindgren A., Brattström L., Norrving B., Hultberg B., Andersson A., Johansson B. B. Plasma homocysteine in the acute and convalescent phases after stroke. Stroke. 1995 May;26(5):795–800. doi: 10.1161/01.str.26.5.795. [DOI] [PubMed] [Google Scholar]
  15. Møller J., Rasmussen K. Homocysteine in plasma: stabilization of blood samples with fluoride. Clin Chem. 1995 May;41(5):758–759. [PubMed] [Google Scholar]
  16. Rasmussen K., Møller J., Lyngbak M., Pedersen A. M., Dybkjaer L. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem. 1996 Apr;42(4):630–636. [PubMed] [Google Scholar]
  17. Rees M. M., Rodgers G. M. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res. 1993 Sep 1;71(5):337–359. doi: 10.1016/0049-3848(93)90160-p. [DOI] [PubMed] [Google Scholar]
  18. Refsum H., Fiskerstrand T., Guttormsen A. B., Ueland P. M. Assessment of homocysteine status. J Inherit Metab Dis. 1997 Jun;20(2):286–294. doi: 10.1023/a:1005321225893. [DOI] [PubMed] [Google Scholar]
  19. Shipchandler M. T., Moore E. G. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem. 1995 Jul;41(7):991–994. [PubMed] [Google Scholar]
  20. Stabler S. P., Lindenbaum J., Savage D. G., Allen R. H. Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood. 1993 Jun 15;81(12):3404–3413. [PubMed] [Google Scholar]
  21. Ubbink J. B., Hayward Vermaak W. J., Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr. 1991 Apr 19;565(1-2):441–446. doi: 10.1016/0378-4347(91)80407-4. [DOI] [PubMed] [Google Scholar]
  22. Ubbink J. B., Vermaak W. J., van der Merwe A., Becker P. J. The effect of blood sample aging and food consumption on plasma total homocysteine levels. Clin Chim Acta. 1992 Apr 30;207(1-2):119–128. doi: 10.1016/0009-8981(92)90155-j. [DOI] [PubMed] [Google Scholar]
  23. Ueland P. M. Homocysteine species as components of plasma redox thiol status. Clin Chem. 1995 Mar;41(3):340–342. [PubMed] [Google Scholar]
  24. Ueland P. M., Refsum H., Stabler S. P., Malinow M. R., Andersson A., Allen R. H. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem. 1993 Sep;39(9):1764–1779. [PubMed] [Google Scholar]
  25. Wilcken D. E. MTHFR 677C-->T mutation, folate intake, neural-tube defect, and risk of cardiovascular disease. Lancet. 1997 Aug 30;350(9078):603–604. doi: 10.1016/S0140-6736(05)63320-X. [DOI] [PubMed] [Google Scholar]
  26. den Heijer M., Koster T., Blom H. J., Bos G. M., Briet E., Reitsma P. H., Vandenbroucke J. P., Rosendaal F. R. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996 Mar 21;334(12):759–762. doi: 10.1056/NEJM199603213341203. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES